Get the Stockscreener App
46.88
0.14%
0.065
After Hours:
46.88
0.005
+0.01%
Astrana Health Inc stock is traded at $46.88, with a volume of 350.11K.
It is up +0.14% in the last 24 hours and up +21.03% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$46.81
Open:
$47.06
24h Volume:
350.11K
Relative Volume:
0.61
Market Cap:
$2.32B
Revenue:
$3.53B
Net Income/Loss:
$30.99M
P/E Ratio:
76.42
EPS:
0.6134
Net Cash Flow:
$154.99M
1W Performance:
-4.67%
1M Performance:
+21.03%
6M Performance:
+64.88%
1Y Performance:
+83.03%
1-Day Range:
$45.50
$48.49
1-Week Range:
$44.93
$50.00
52-Week Range:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
46.88 | 2.32B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
406.59 | 90.20B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.25 | 17.59B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
232.80 | 14.94B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 12.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.16 | 10.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Price to earnings forward of Astrana Health Inc. – DUS:3AM - TradingView
Astrana Health (ASTH) Stock Trades At A Premium On Earnings But Strong On Returns - simplywall.st
Astrana Health, Inc. (ASTH) surges 7.3%: Is this an indication of further gains? - MSN
Astrana Health earnings ahead: Can value-based model sustain growth? - Investing.com
ASTH Technical Analysis & Stock Price Forecast - Intellectia AI
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum - ChartMill
Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains? - Yahoo Finance
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
Astrana Health Chief Accounting Officer to Retire - Moomoo
Astrana Health, Inc. Files SEC Form 8-K: Key Details on NASDAQ-Listed ASTH Stock and Company Information - Minichart
Astrana Health (NASDAQ: ASTH) taps John Vong as new accounting head - Stock Titan
Astrana Health Jumps 7.1% Amid Sector-Wide Rally - AlphaStreet
A Look at Astrana Health Inc (ASTH) After 3.1% Gain -- GF Value $82.34 vs Price $46.41 - GuruFocus
Form 4 Astrana Health Inc For: 30 June By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) CEO Brandon Sim logs tax-withholding share disposition and updated holdings - Stock Titan
Astrana Health stock hits 52-week high at 45.11 USD - Investing.com
Astrana Health stock hits 52-week high at 45.11 USD By Investing.com - Investing.com Nigeria
Astrana Health, Inc. Hits New 52-Week High of USD 41.23 - MarketsMojo
Astrana Health Inc. Actuals & Estimates (NASDAQ:ASTH) - TradingView
Enterprise value to EBIT forward of Astrana Health Inc. – NASDAQ:ASTH - TradingView
Enterprise value to EBITDA forward of Astrana Health Inc. – NASDAQ:ASTH - TradingView
Price to book forward of Astrana Health Inc. – NASDAQ:ASTH - TradingView
3AM Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Astrana Health Inc. – MUN:3AM - TradingView
Price to book forward of Astrana Health Inc. – MUN:3AM - TradingView
Price to sales forward of Astrana Health Inc. – MUN:3AM - TradingView
Enterprise value to revenue forward of Astrana Health Inc. – MUN:3AM - TradingView
Astrana Health Inc. Actuals & Estimates (HAM:3AM) - TradingView
ASTH Stock Price, Quote & Chart - ChartMill
Astrana Health Inc. Actuals & Estimates (LSX:A14SUE) - TradingView
ASTH Forecast — Price Target — Prediction for 2027 - TradingView
A14SUE Forecast — Price Target — Prediction for 2027 - TradingView
Astrana Health stock hits 52-week high at 40.35 USD By Investing.com - Investing.com South Africa
Is Astrana Health's (ASTH) ESOP Shelf Filing Quietly Reframing Its Value‑Based Care Narrative? - simplywall.st
Astrana Health stock hits 52-week high at 40.35 USD - Investing.com UK
Astrana Health (ASTH) Gets Upgraded by Barclays - Yahoo Finance
Astrana Health Inc (ASTH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Astrana Health Inc (ASTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Astrana Health Inc (ASTH) Institutional Confidence - TradingKey
Astrana Health Inc (ASTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Astrana Health Inc (ASTH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Astrana Health Inc (ASTH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Astrana Health Inc (ASTH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Astrana Health Inc (ASTH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Astrana Health Inc. (ASTH) Retreats 3.09% as Selling Pressure Tests Key Support LevelsNaked POC - newsline.com
Astrana Health, Inc. Hits New 52-Week High at $40.02 - MarketsMojo
Is Astrana Health Inc (ASTH) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (ASTH) director receives 4,525 restricted stock award - Stock Titan
Director Mazdyasni granted 4,525 Astrana Health (ASTH) restricted shares vesting in 2027 - Stock Titan
Astrana Health (ASTH) director gets 4,991 new restricted shares - Stock Titan
Astrana Health (ASTH) director Weili Dai receives 4,525-share restricted stock grant - Stock Titan
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Astrana Health Inc Stock (ASTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schmidt David | Director |
Jan 13 '26 |
Option Exercise |
5.79 |
20,000 |
115,800 |
35,763 |
| Lam Thomas S. | Director |
Dec 08 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
459,122 |
| Sim Kenneth T. | Executive Chairman |
Nov 10 '25 |
Option Exercise |
17.78 |
29,502 |
524,546 |
639,407 |
| Kitayama Mitchell W | Director |
Nov 07 '25 |
Option Exercise |
18.20 |
12,000 |
218,400 |
27,846 |
| Mazdyasni Matthew | Director |
Nov 10 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
34,763 |
| Marsh Linda | Director |
Nov 03 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
103,641 |
| Kitayama Mitchell W | Director |
Sep 15 '25 |
Option Exercise |
18.20 |
8,000 |
145,600 |
29,060 |
| Schmidt David | Director |
Sep 02 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
35,763 |
| Chiang John | Director |
Aug 13 '25 |
Option Exercise |
18.20 |
20,000 |
364,000 |
43,132 |
0.88%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):